Legend Biotech Corp Noncurrent Restricted Cash And Cash Equivalents
Legend Biotech Corp (LEGN) had Noncurrent Restricted Cash And Cash Equivalents of $0 as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:NoncurrentRestrictedCashAndCashEquivalents · last filed 2026-03-10
- 2025-12-31: Noncurrent Restricted Cash And Cash Equivalents $0.00.
- 2024-12-31: Noncurrent Restricted Cash And Cash Equivalents $4.40M.
- 2023-12-31: Noncurrent Restricted Cash And Cash Equivalents $4.40M.
| Period end | Noncurrent Restricted Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-10 |
| 2024-12-31 | $4.40M 20-F · filed 2026-03-10 |
| 2023-12-31 | $4.40M 20-F · filed 2025-03-11 |